Cargando…

Evolution of bacteria specialization along an antibiotic dose gradient

Antibiotic and pesticide resistance of pathogens are major and pressing worldwide issues. Resistance evolution is often considered in simplified ecological contexts: treated versus nontreated environments. In contrast, antibiotic usually present important dose gradients: from ecosystems to hospitals...

Descripción completa

Detalles Bibliográficos
Autores principales: Harmand, Noémie, Gallet, Romain, Martin, Guillaume, Lenormand, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121860/
https://www.ncbi.nlm.nih.gov/pubmed/30283678
http://dx.doi.org/10.1002/evl3.52
_version_ 1783352550452363264
author Harmand, Noémie
Gallet, Romain
Martin, Guillaume
Lenormand, Thomas
author_facet Harmand, Noémie
Gallet, Romain
Martin, Guillaume
Lenormand, Thomas
author_sort Harmand, Noémie
collection PubMed
description Antibiotic and pesticide resistance of pathogens are major and pressing worldwide issues. Resistance evolution is often considered in simplified ecological contexts: treated versus nontreated environments. In contrast, antibiotic usually present important dose gradients: from ecosystems to hospitals to polluted soils, in treated patients across tissues. However, we do not know whether adaptation to low or high doses involves different phenotypic traits, and whether these traits trade‐off with each other. In this study, we investigated the occurrence of such fitness trade‐offs along a dose gradient by evolving experimentally resistant lines of Escherichia coli at different antibiotic concentrations for ∼400 generations. Our results reveal fast evolution toward specialization following the first mutational step toward resistance, along with pervasive trade‐offs among different evolution doses. We found clear and regular fitness patterns of specialization, which converged rapidly from different initial starting points. These findings are consistent with a simple fitness peak shift model as described by the classical evolutionary ecology theory of adaptation across environmental gradients. We also found that the fitness costs of resistance tend to be compensated through time at low doses whereas they increase through time at higher doses. This cost evolution follows a linear trend with the log‐dose of antibiotic along the gradient. These results suggest a general explanation for the variability of the fitness costs of resistance and their evolution. Overall, these findings call for more realistic models of resistance management incorporating dose‐specialization.
format Online
Article
Text
id pubmed-6121860
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61218602018-10-03 Evolution of bacteria specialization along an antibiotic dose gradient Harmand, Noémie Gallet, Romain Martin, Guillaume Lenormand, Thomas Evol Lett Letters Antibiotic and pesticide resistance of pathogens are major and pressing worldwide issues. Resistance evolution is often considered in simplified ecological contexts: treated versus nontreated environments. In contrast, antibiotic usually present important dose gradients: from ecosystems to hospitals to polluted soils, in treated patients across tissues. However, we do not know whether adaptation to low or high doses involves different phenotypic traits, and whether these traits trade‐off with each other. In this study, we investigated the occurrence of such fitness trade‐offs along a dose gradient by evolving experimentally resistant lines of Escherichia coli at different antibiotic concentrations for ∼400 generations. Our results reveal fast evolution toward specialization following the first mutational step toward resistance, along with pervasive trade‐offs among different evolution doses. We found clear and regular fitness patterns of specialization, which converged rapidly from different initial starting points. These findings are consistent with a simple fitness peak shift model as described by the classical evolutionary ecology theory of adaptation across environmental gradients. We also found that the fitness costs of resistance tend to be compensated through time at low doses whereas they increase through time at higher doses. This cost evolution follows a linear trend with the log‐dose of antibiotic along the gradient. These results suggest a general explanation for the variability of the fitness costs of resistance and their evolution. Overall, these findings call for more realistic models of resistance management incorporating dose‐specialization. John Wiley and Sons Inc. 2018-05-08 /pmc/articles/PMC6121860/ /pubmed/30283678 http://dx.doi.org/10.1002/evl3.52 Text en © 2018 The Author(s). Evolution Letters published by Wiley Periodicals, Inc. on behalf of Society for the Study of Evolution (SSE) and European Society for Evolutionary Biology (ESEB). This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters
Harmand, Noémie
Gallet, Romain
Martin, Guillaume
Lenormand, Thomas
Evolution of bacteria specialization along an antibiotic dose gradient
title Evolution of bacteria specialization along an antibiotic dose gradient
title_full Evolution of bacteria specialization along an antibiotic dose gradient
title_fullStr Evolution of bacteria specialization along an antibiotic dose gradient
title_full_unstemmed Evolution of bacteria specialization along an antibiotic dose gradient
title_short Evolution of bacteria specialization along an antibiotic dose gradient
title_sort evolution of bacteria specialization along an antibiotic dose gradient
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121860/
https://www.ncbi.nlm.nih.gov/pubmed/30283678
http://dx.doi.org/10.1002/evl3.52
work_keys_str_mv AT harmandnoemie evolutionofbacteriaspecializationalonganantibioticdosegradient
AT galletromain evolutionofbacteriaspecializationalonganantibioticdosegradient
AT martinguillaume evolutionofbacteriaspecializationalonganantibioticdosegradient
AT lenormandthomas evolutionofbacteriaspecializationalonganantibioticdosegradient